Request Sample Form

Name*:

Phone No.*:

Email*:

Service Intersted In:

Download Complete Report

Your Name*:

Email*:

Contact Number*:

Subject*:

Service Interested In* (required)

Your Requirment*:

Possible drug target for lung cancer by manipulating tumor suppressor protein Rb

Tumours often become resistant to treatment, but how this occurs is poorly understood. An analysis of how the protein Rb affects tumour growth and the response to therapy might cast light on the problem.

May 1st, 2019|News|

Study by MIT researchers could pave the way for new therapies for Alzheimers

Researchers performed the first comprehensive analysis of the genes altered in individual brain cells of patients with Alzheimer’s disease, allowing them to identify the distinctive cellular pathways affected in neurons and other types of brain cells.

May 1st, 2019|News|

ViiV submits NDA for first long-acting, injectable HIV combo

ViiV Healthcare has submitted a new drug application to the US Food and Drug Administration (FDA) for the first ever monthly, injectable, two-drug regimen of cabotegravir and Edurant (rilpivirine) for treatment of HIV.

May 1st, 2019|News|

Bayer, Orion win FDA priority review for darolutamide in prostate cancer

The US Food and Drug Administration (FDA) has accepted a new drug application for review and granted priority review for darolutamide.

May 1st, 2019|News|